期刊： EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021; 50 ()
(R,S)-ketamine causes rapid-acting and sustained antidepressant effects in treatment-resistant patients with depression although the precise molecular......
期刊： EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021; 47 ()
This study systematically compared duration of untreated illness (DUI) with duration of untreated psychosis (DUP) in prediction of impairment at first......
期刊： EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021; 45 ()
Physical inactivity, the fourth leading mortality risk factor worldwide, is associated with chronic mental illness. Identifying the mechanisms underly......
期刊： EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021; 46 ()
Psychiatry qualifications are automatically recognized among European Union (EU) countries despite differences in national training programs. A wideni......
期刊： EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021; 42 ()
Bipolar disorder (BD) is a severe mental illness affecting 2% of the global population. Current pharmacotherapies provide incomplete symptom remediati......
期刊： EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021; 43 ()
Brain gray matter is organized in a manner with interconnected brain regions, resulting in a notable covariance pattern that recapitulates either the ......
期刊： EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021; 43 ()
Cannabinoids produce both rewarding and aversive effects in humans and experimental animals. However, the mechanisms underlying these conflicting find......
期刊： EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020; 31 ()
Methamphetamine is the most commonly used illicit drug in China. We previously demonstrated that 10 Hz rTMS over the DLPFC reduces craving in methamph......
期刊： EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020; 31 ()
Evidence shows that schizophrenia is associated with increased incidence of stroke. However, relationship between schizophrenia and short-term mortali......
期刊： EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020; 31 ()
Expectancies of nicotine content have been shown to impact smokers' subjective responses and smoking behaviors. However, little is known about the neu......
期刊： EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020; 35 ()
Hippocampal volume deficits have been reported in chronically-treated schizophrenia patients, however, the longer-term effects of antipsychotic medica......
期刊： EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020; 36 ()
Reward-seeking and relief from negative emotions are two central motivational drives underlying addictions. Impaired executive control over craving an......
